Phosphoinositide 3-kinase in health and disease Volume 2

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Cijeli opis

Bibliografski detalji

Autor kompanije:	SpringerLink (Online service)
Daljnji autori:	Rommel, Christian, Vanhaesebroeck, Bart, Vogt, Peter K.
Format:	Electronic Resource
Jezik:	English
Izdano:	Berlin, Heidelberg Springer 2011.
Serija:	Current Topics in Microbiology and Immunology 347
Teme:	Protein kinases. Protein-tyrosine kinase > Inhibitors. Protein kinase inhibitors > Therapeutic use. Protein kinases > Physiology. Electronic books.
Online pristup:	Available for University of the Philippines Diliman via SpringerLink. Click here to access